We have used two strategies to study 14 hemophilia B families from 11 kindreds for possible carrier detection and prenatal diagnosis. First, we sequentially used the Factor IX probes (sequentially with restriction enzymes Taq I, Xmn I, and Dde I), and the linked probes p45h (Taq I), p45d (Pst I), and 52a (Taq I) for restriction fragment length polymorphism (RFLP) analysis.
Introduction
Hemophilia B (Christmas disease) is an X-linked hereditary bleeding disorder with functional deficiency ofFactor IX, which affects -1:25,000 males (1) . Female relatives of patients with hemophilia B often wish to know if they are carriers of this disorder, but only obligate carriers can be identified by pedigree analysis. Carrier detection by assaying for coagulant Factor IX activity (IX:C)' alone, or in combination with Factor IX-related antigen (IX:Ag), lacks accuracy (1) . Recently, the gene coding for Factor IX has been cloned and characterized (2) (3) (4) , with the nucleotide sequence of the entire gene elucidated (5, 6) . The complementary DNA (cDNA) and genomic probes have been successfully applied to track the affected X chromosome by re-1. Abbreviations used in this paper: IX:Ag, Factor IX-related antigen; IX:C, coagulant Factor IX activity; RFLP, restriction fragment length polymorphism. striction fragment length polymorphism (RFLP) studies for the accurate detection of carriers (7) (8) (9) (10) (11) (12) (13) (14) . Initial studies with the restriction enzyme Taq I suggested that only 45% ofthe families had informative RFLP patterns (7) . More recently, Xmn 1 (9), Dde I/Hinf I (9), Bam HI (12, 13) , and Msp I (14) Factor IX intragenic RFLPs have been characterized, and it was estimated that about two-thirds of the families will be informative when Taq I, Xmn I and Dde I/Hinf I were used (9) .
We have studied 1 hemophilia B kindreds for the detection of female carriers, and determined their suitability for future prenatal diagnosis using the same markers. In addition to using Factor IX cDNA and genomic probes to look for known RFLPs, we also used the cDNA probe to specifically look for Taq I variants as markers for the affected X chromosome. For the families that are not informative with these Factor IX probes, we have performed additional studies with probes to DNA segments closely linked to the Factor IX gene (52a, p45h, and p45d) in an attempt to increase the proportion of informative families.
Methods
Subjects. Members from 11 hemophilia B kindreds were studied. Nine of these kindreds are Caucasian, and two are Oriental. In nine of the kindreds, more than one affected male (with hemophilia B) are present. This is consistent with the mothers ofthe probands being obligate carriers of the defective Factor IX gene. The probands in the remaining two kindreds (kindreds B and D, Table I ) are the only known affected males within these kindreds. All the patients studied had severe disease with IX:C < 0.01 U/ml as measured by the modified one-stage partial thromboplastin time assay (15) , and none had developed inhibitors.
Gene probes. The Factor IX probes used include cDNA (2, 3) and genomic probe VIII, which spans exon IV (7) . In some experiments, the 5' and 3' end of the Factor IX cDNA probe were derived by double digestion with Pst I (to excise insert) and Ava I (to generate 5' 674-base pair and 3' 763-base pair probes). These were identified respectively as 5'-cDNA and 3'-cDNA probes. Probes to regions linked to the Factor IX gene used include 52a (16) , as well as p45h and p45d, which are two subclones of pX45D (17) . All probe inserts were freed of vector by restriction digestion and electroelution before labeling using [32P]dCTP and random primers (18).
Restriction enzyme analysis. Genomic DNA was isolated from the leukocytes in 7-10 ml of fresh or frozen-thawed EDTA-anticoagulated peripheral blood according to previously described methods (19, 20 
Results
RFLP analysis 12 ofthe 13 patient-mother pairs and one patient-daughter pair in the 11 kindreds were studied sequentially using the appropriate Factor IX probes (sequentially with Taq I, Xmn I, and Dde I), p45h and 52a (Taq I), and p45d (Pst I), until heterozygosity of the polymorphic fragments of the females could be obtained (Table I ). Kindred B was studied only with the Factor IX probes. Five mothers (families Al, C, D, E and F) were heterozygous using the genomic Factor IX probe/Taq I enzyme combination alone. Sequential studies on the remaining showed two additional informative mothers (familes A2 and A3) with the genomic Factor IX probe/Xmn I combination; one additional (family G) with the p45h probe/Taq I combination; and two additional (families H and I) with the 52a probe/Taq I combination. Thus, a total of 10 out of 14 females were informative. Family studies were carried out for seven of the patient-mother pairs in five kindreds (Table I) .
KindredA. Families Al, A2, and A3 are from a large kindred, with the mothers being daughters of a man with Christmas disease. Mother Al was informative with the genomic IX probe/ Taq I combination, and her daughter was identified as carrier who was heterozygous for the polymorphic fragments suitable for future prenatal diagnosis. Mother A2 was informative for the genomic IX probe/Xmn I combination, and her daughter was identified as a noncarrier. Mother A3 was informative for the genomic IX probe/Xmn I combination, and both of her daughters were identified as carriers but were homozygous for the polymorphic fragments. Sequential probe/enzyme analysis show both daughters were informative with the p45h probe/Taq I combination for future prenatal diagnosis. The mother in family A3 was also informative with the 52a probe/Taq I combination and family studies confirmed the carrier status ofthe two daughters (Table I) .
Kindred B. The genomic IX probe/Taq I RFLPs could be used to exclude carrier status in the maternal aunt. However, neither Taq I nor Xmn I RFLPs were informative in the mother. Kindred C. Genomic IX probe/Taq I analysis indicates that the daughter is a carrier, but this would not be informative for future prenatal diagnosis. Sequential studies established that the cDNA probe/Dde I combination could be used for this purpose. The results on two independent sets of specimens are identical, and nonpaternity is evident in this family.
Kindred D. The genomic IX probe/Taq I analysis shows that neither of the daughters carries the X chromosome of the proband, which indicates that they are not carriers.
Kindred E. Genomic IX probe/Taq I analysis shows that the daughter is not a carrier.
Detection ofunusual Taq I variants
Variant Taq I fragments were found in patients of kindreds A and B. All these patients had severe disease (IX:C < 0.01 U/ml) with the IX:Ag < 0.06 U/ml by the Laurell immunoelectrophoresis assay (23) .
KindredA. Each ofthe three patients had a 1.3-kilobase (kb) fragment with the genomic probe/Taq I RFLP (Table I , Fig. 1 a). Independent Taq I digestion as well as repeat hybridization studies with the total cDNA probe revealed that all three patients had both 1.3-and 1.8-kb fragments with loss of the constant 1.5-kb fragment ( Fig. 1 b and Table I ). In contrast, the 3' cDNA probe disclosed a 1.8-kb fragment in each ofthese patients instead of the 1.5-kb fragment normally found (data not shown). These results indicate that the 1.8-kb fragment is a new variant due to the loss ofa Taq I site that would normally result in the constant 1.5-kb Taq I fragment, and that the changed Taq I site is 3' to the Ava I cDNA digestion site (Fig. 2) . Hybridization of Xmn I DNA digest by the 3' and 5' cDNA probes showed normal fragment patterns (identical to the patterns in Fig. 3, b and d) , excluding the possibility of a gross gene deletion to account for the Taq I variant pattern. Based on the sequence published by Yoshitake et al. (5), and a computer search, the Taq I digestion site (TCGA) change could be traced to exon VIII at nucleotides 30873 to 30876. Studies using both the genomic and cDNA probes confirmed that the variant 1.8-kb fragment was present in each obligate carrier and in each ofthe two carriers identified by RFLP analysis (Fig. 1 , a and b, and Table I ).
Kindred B. Total cDNA analysis of Taq I digests from the only known Christmas disease patient in this family disclosed a variant 3.0-kb fragment with loss ofthe constant 2.7-kb fiagment.
These changes in fragment size could be discerned using the 3'-cDNA probe (Fig. 3 c) , while the 2.7-kb and the 3.0-kb fragments were absent when the 5'-cDNA probe was used (Fig. 3 a) . In addition, the Xmn I fragments were unchanged (Fig. 3, b and  d ). These studies suggest that the 3.0-kb fragment is a result of a loss of a Taq I site that would normally result in a 2.7-kb fragment after Taq I digestion (Fig. 2) . Based on the nucleotide sequence published by Yoshitake et al. (5) and on a computer search, the Taq I digestion site (TCGA) change could be traced to exon VIII, at nucleotides 31131 to 31 134. The same variant 3.0-kb fragment could be identified in the mother and maternal grandmother, who are therefore carriers, but not in the maternal aunt (whose carrier status was also excluded by RFLP analysis) (Fig. 3 c and Table I ).
Discussion
We have studied 11 hemophilia B kindreds with DNA probes for carrier detection and for assessment of prenatal diagnosis possibilities amongst the carriers. Our approach was to sequentially study the female relatives with Factor IX probes (cDNA and genomic probe VIII), and linked probes (p45h, 52a, and p45d) for the known RFLPs and to identify Factor IX variants. Of the 13 mothers and 1 daughter of probands from these 11 kindreds, 11 mothers (79%) from 9 kindreds (Table I) were informative (heterozygous for the RFLPs, or possession of variant fragments found in the patients). This proportion is higher than the 40-66% using Factor IX RFLP analysis alone (7) (8) (9) (10) (11) (12) . We determined the carrier status of all 11 at risk females in 5 kindreds, and also determined that prenatal diagnosis could be offered to the offsprings of each of the 6 carriers identified.
Using the Factor IX probes, RFLP studies with Taq I and Xmn I identified 7 females informative out of 14 (50%) in the 11 kindreds. This proportion is similar to that reported by others (9) . The additional Dde I RFLP should provide a further 16%
informative females (9), but was not useful in our small series. and 52a fragments are identified by brackets with constant fragments followed by the letter c. The numbers across the top correspond to those of the family A3 in Table I , and lane c is a 1.8/1.3-kb unrelated for the blacks (12) , and the Msp I site is located at a short distance from the Taq I site, such that the two RFLPs might be expected to show significant linkage disequilibrium (14) , limiting its usefulness. RFLP studies with the linked probes has provided informative results for three additional mothers, one with p45h and two with 52 (Table I) . Both of these linked probes have Taq I RFLPs and could be easily studied by simultaneous hybridization ofthe filters containing Taq I digested DNA fragments originally used for Factor IX probes (Fig. 1) . A potential problem with this approach is the possible recombination between the Factor IX gene and the linked DNA fragments (24) . To our knowledge, recombination has not yet been reported between the Factor IX and p45h or p45d probes; however, recombination frequency of 1:55 has been reported for the Factor IX and 52a genes (16) .
It is of note that nonpaternity was documented in one family (kindred C). This finding has not affected the carrier state determination on the daughter or altered the ability to provide her with prenatal diagnosis in the future (Table I) . If unrecognized, nonpaternity could negate the predictive value of this type of study.
We have also identified variant Taq I fragments in 2 of 11 kindreds using the total cDNA probe. In kindred A, a 1.8-kb fragment was identified in place ofthe 1 (27) . The change in Taq I fragment size in each case without loss of other constant fragments and the absence of changes with Xmn I (Fig. 3 , and data not shown) suggest that a deletion (unless very small) is unlikely. None of the patients affected produce inhibitor, a frequent association with Factor IX defects produced by gross gene deletions (28) (29) (30) . The precise nature of the Taq I site change in each case will require nucleotide sequencing, which is now under way in our laboratories.
These variant Taq I fragments are useful in tracking the affected X chromosome. They have been used here to successfully determine the carrier status of the female relatives and for future prenatal diagnoses. In family A3, the variant fragment would be superior to the linked probe 52a for this purpose, as possible recombination is a concern whenever linked probes are used.
cluster of fragments from 6.5 to 4.5 kb) and the numbers across the top correspond to the members of family B in Table I . The filters were first probed with the 3' cDNA (c and d), and after 1 wk reprobed with the 5' cDNA (a and b).
Our studies illustrate the importance of using both total cDNA and genomic probes for study of Christmas disease families. The identification of variant fragments would not have been possible with the genomic probe alone. In another study, the cDNA probe was useful for the identification of a Factor IX intragenic deletion (31) . On the other hand, the fragment pattern from the cDNA probe/Taq I in kindred A would have been extremely difficult to interpret without the RFLP patterns from the genomic probe, as the variant 1.8-kb fragment is identical in size to one of the Taq I RFLPs.
Two of the kindreds (B and D) had no family history of hemophilia and a new mutation affecting only the prpband could not be excluded. It is of interest that in family B, the variant fragment observed in the affected child is also present in the previous two generations. Kindred D could only be studied by RFLP approach. In this instance, the result is valid only when the female relatives are identified not as carriers, as is the case with the daughters of this family. The noncarrier status of the maternal aunt of kindred B could also be predicted by RFLP studies. Many female relatives ofhemophilia patients desire to know ifthey are carriers, and genetic counseling has become an integral part of the comprehensive hemophilia management. Some female carriers often wish to learn more about the upbringing of a hemophilic child, and the coping with emotions and schooling (32 (33) .
